Protein-Protein Interactions with MRAS: A Powerful Tool for Drug Targets and Biomarkers

Target Name: MRAS

NCBI ID: G22808

MRAS

Protein-Protein Interactions with MRAS: A Powerful Tool for Drug Targets and Biomarkers

Molecular ruler activity-based screening (MRAS) is a strategy for identify and quantify protein-protein interaction (PPI) events in living cells. It is a powerful tool for the identification of potential drug targets, biomarkers, and disease markers. MRAS is a widely used screening approach that has been applied to various cellular systems, including bacteria, yeast, plants, and animals. In this article, we will discuss MRAS, its application, and potential as a drug target.

History of MRAS

MRAS was first introduced in the early 1990s by Dr. Yoshiko Sato at the University of Tokyo. The original MRAS screening method used the protein-protein interaction inhibitor GST-P200, which can interact with any protein as long as it has a active surface. This method allowed researchers to identify protein-protein interactions with high accuracy. Since then, several variations of MRAS have been developed, including MRAS-1, MRAS-2, and MRAS-3.

MRAS-1

MRAS-1 is a widely used MRAS system that uses the protein-protein interaction inhibitor GST-P200. It is based on the principle of Michaelis-Menten kinetics, where the rate of an interaction increases as the concentrations of both proteins increase. GST-P200 has been shown to be a powerful inhibitor of protein-protein interactions and can interact with a wide range of proteins.

The MRAS-1 screening protocol involves the following steps: 1) expression of the luciferase gene, 2) introduction of the GST-P200 protein inhibitor, 3) incubation of the cells, and 4) detection of the luciferase activity. The activity of the cells is measured using a luminometer, and the activity level is compared to a control cell or a reference cell. If the activity level is higher than the control or reference cell, it suggests that the protein interacts with the inhibitor.

MRAS-2

MRAS-2 is an improved version of MRAS that uses a more sensitive assay method to measure protein-protein interactions. It is based on the principle of stoichiometric inhibition, where the activity of the interaction is inhibited when the concentration of one of the proteins exceeds a certain value. This method allows for the detection of interactions with high precision.

The MRAS-2 screening protocol involves the following steps: 1) expression of the luciferase gene, 2) introduction of the protein-protein interaction inhibitor, 3) incubation of the cells, and 4) detection of the luciferase activity. The activity of the cells is measured using a luminometer, and the activity level is compared to a control cell or a reference cell. If the activity level is higher than the control or reference cell, it suggests that the protein interacts with the inhibitor.

MRAS-3

MRAS-3 is an extension of MRAS that uses a more sensitive assay method to measure protein-protein interactions. It is based on the principle of stoichiometric inhibition, where the activity of the interaction is inhibited when the concentration of one of the proteins exceeds a certain value. This method allows for the detection of interactions with high precision.

The MRAS-3 screening protocol involves the following steps: 1) expression of the luciferase gene, 2) introduction of the protein-protein interaction inhibitor, 3) incubation of the cells, and 4) detection of the luciferase activity. The activity of the cells is measured using a luminometer, and the activity level is compared to a control cell or a reference cell. If the activity level is higher than the control or reference cell, it suggests that the protein interacts with the inhibitor.

Applications of MRAS

MRAS has been applied to various cellular systems to identify and quantify protein-protein interactions. Some of the applications include:

1. Identification of potential drug targets: MRAS can be used to identify potential

Protein Name: Muscle RAS Oncogene Homolog

Functions: Serves as an important signal transducer for a novel upstream stimuli in controlling cell proliferation. Activates the MAP kinase pathway

The "MRAS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRAS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets